简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-10-23 16:28 CE Mark Granted for Novel Cryoablation Device Aimed at Reducing the Incidence of Esophageal Cancer
2015-10-23 16:00 Quintiles and IMS Health Announce Global Collaboration to Advance the Use of Next-Generation Real-World Evidence in Late-Stage Clinical Research
2015-10-21 15:11 Quintiles Names Kevin Gordon as COO, Appoints Mike McDonnell as CFO
2015-10-21 14:43 ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China
2015-10-21 14:20 Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at ACG Plenary Session
2015-10-21 14:00 Sinophi Healthcare Ltd: Seven China hospital deals worth £800 million focused on proton therapy to treat cancer
2015-10-20 10:00 Premier Biomedical and Auramedi Farmacêutica Agree to Explore Forming Joint Venture in Brazil
2015-10-19 16:01 FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate)
2015-10-19 14:26 New CPR Guidelines Recommend Using Social Media and Mobile Technology to Speed Bystander CPR in Sudden Cardiac Arrests
2015-10-16 17:51 GN ReSound and Cochlear Limited Establish Smart Hearing Alliance to Develop and Commercialise Bimodal Solutions
2015-10-16 17:11 One Year on, Allianz Worldwide Care’s MyHealth App Hits 100,000 Member Claim Submissions
2015-10-16 14:15 Quintiles Named 2015 Frost & Sullivan Asia Pacific CRO Company of the Year
2015-10-16 10:04 Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development
2015-10-15 13:45 Quintiles Recognized as Phase I Services Leader for Third Consecutive Year
2015-10-15 09:55 Joe Kiani to Deliver Keynote Address at Brazil’s Inaugural Foundation for Patient Safety Symposium
2015-10-14 14:37 Cell Signaling Technology Expands Portfolio with GMP Capabilities
2015-10-14 14:27 Jubilant DraxImage launches HICON® in Colombia
2015-10-14 13:25 One Year Data from Phase III Study Evaluating Oral OTEZLA® (apremilast) or Injectable etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at EADV
2015-10-13 17:37 Olea Medical to Join Toshiba Medical Systems Corporation Group
2015-10-13 15:54 Arcadia Biosciences Receives US Patent for Resistant Starch Wheat Technology

Business Wire Weibo

Press Releases

Latest Releases